Elevance Health Inc.

482.76-1.21-0.25%Vol 197.49K1Y Perf 29.70%
Aug 10th, 2022 13:30 DELAYED
BID482.73 ASK483.22
Open488.84 Previous Close483.97
Pre-Market489.99 After-Market-
 6.02 1.24%  - -
Target Price
554.63 
Analyst Rating
Strong Buy 1.46
Potential %
14.65 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     46.24
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★     38.99
Price Range Ratio 52W %
71.43 
Earnings Rating
Market Cap115.86B 
Earnings Date
20th Jul 2022
Alpha0.01 Standard Deviation0.08
Beta0.96 

Today's Price Range

482.76489.87

52W Range

355.43533.68

5 Year PE Ratio Range

9.3026.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.93%
1 Month
-0.07%
3 Months
-0.84%
6 Months
6.33%
1 Year
29.70%
3 Years
74.76%
5 Years
171.10%
10 Years
871.40%

TickerPriceChg.Chg.%
ELV482.76-1.2100-0.25
AAPL168.063.14001.90
GOOG120.883.38002.88
MSFT288.356.04502.14
XOM91.480.88990.98
WFC44.591.18502.73
JNJ169.82-0.3600-0.21
FB196.640.99000.51
GE77.472.54003.39
JPM118.302.92002.53
 
ProfitabilityValueIndustryS&P 500US Markets
-
6.20
-
4.90
4.04
RevenueValueIndustryS&P 500US Markets
110.50B
458.34
-
-
DividendsValueIndustryS&P 500US Markets
1.06
5.12
13.94
11.77
Payout ratio-
Earnings HistoryEstimateReportedSurprise %
Q02 20227.728.044.15
Q01 20227.818.255.63
Q04 20215.115.140.59
Q03 20216.356.796.93
Q02 20216.347.0310.88
Q01 20216.867.012.19
Q04 20202.572.54-1.17
Q03 20204.044.203.96
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report7.72
Estimates Count16
EPS Growth Next 5 Years %-
Volume Overview
Volume197.49K
Shares Outstanding240.00K
Shares Float240.81M
Trades Count6.81K
Dollar Volume95.77M
Avg. Volume890.55K
Avg. Weekly Volume647.34K
Avg. Monthly Volume932.46K
Avg. Quarterly Volume1.09M

Elevance Health Inc. (NYSE: ELV) stock closed at 483.97 per share at the end of the most recent trading day (a 1.73% change compared to the prior day closing price) with a volume of 796.27K shares and market capitalization of 115.86B. Is a component of S&P 500 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 98200 people. Elevance Health Inc. CEO is Gail Koziara Boudreaux.

The one-year performance of Elevance Health Inc. stock is 29.7%, while year-to-date (YTD) performance is 4.97%. ELV stock has a five-year performance of 171.1%. Its 52-week range is between 355.4333 and 533.68, which gives ELV stock a 52-week price range ratio of 71.43%

Elevance Health Inc. currently has a PE ratio of 19.20, a price-to-book (PB) ratio of 3.28, a price-to-sale (PS) ratio of 1.05, a price to cashflow ratio of 14.30, a PEG ratio of 2.32, a ROA of 6.54%, a ROC of -% and a ROE of 18.38%. The company’s profit margin is 4.04%, its EBITDA margin is -%, and its revenue ttm is $110.50 Billion , which makes it $458.34 revenue per share.

Of the last four earnings reports from Elevance Health Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $7.72 for the next earnings report. Elevance Health Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Elevance Health Inc. is Strong Buy (1.46), with a target price of $554.63, which is +14.65% compared to the current price. The earnings rating for Elevance Health Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elevance Health Inc. has a dividend yield of 1.06% with a dividend per share of $5.12 and a payout ratio of -%.

Elevance Health Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.52, ATR14 : 12.72, CCI20 : 99.90, Chaikin Money Flow : 0.05, MACD : 0.29, Money Flow Index : 52.89, ROC : 5.30, RSI : 55.84, STOCH (14,3) : 86.58, STOCH RSI : 1.00, UO : 51.15, Williams %R : -13.42), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elevance Health Inc. in the last 12-months were: Charles Morgan Kendrick (Option Excercise at a value of $1 806 785), Charles Morgan Kendrick (Sold 6 328 shares of value $3 091 872 ), Peter Haytaian (Option Excercise at a value of $243 566), Peter Haytaian (Sold 17 703 shares of value $8 155 862 ), Ramiro G. Peru (Sold 990 shares of value $464 191 ), Robert L. Dixon (Sold 420 shares of value $208 799 ), Ronald W. Penczek (Option Excercise at a value of $1 171 799), Ronald W. Penczek (Sold 5 186 shares of value $2 376 461 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (76.92 %)
11 (78.57 %)
9 (69.23 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (7.69 %)
Hold
3 (23.08 %)
3 (21.43 %)
3 (23.08 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.46
Strong Buy
1.43
Strong Buy
1.50

Elevance Health Inc.

Anthem remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members. The company offers employer, individual, and government-sponsored coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Anthem's reach expands beyond those states through government-sponsored programs such as Medicaid, too.

CEO: Gail Koziara Boudreaux

Telephone: +1 800 331-1476

Address: 220 Virginia Avenue, Indianapolis 46204, IN, US

Number of employees: 98 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

100%0%

TipRanks News for ELV

Mon, 25 Jul 2022 16:30 GMT Elevance Health (ELV) Gets a Hold Rating from Morgan Stanley

- TipRanks. All rights reserved.

Fri, 22 Jul 2022 09:41 GMT Elevance Health (ELV) Gets a Buy Rating from Jefferies

- TipRanks. All rights reserved.

Thu, 21 Jul 2022 12:26 GMT Elevance Health (ELV) Receives a Rating Update from a Top Analyst

- TipRanks. All rights reserved.

News

Stocktwits